Monitoring agency report for the quarter ended June 30 2026

EBIX LIMITED (Formerly known as Eraaya Lifespaces Limited) CIN: L 74899 DL 1967 PLC 004704 Corporate Office: Vikas House,3, Arihant Nagar Punjabi Bagh West, Delhi-110026 Listing Compliance Department August 14, 2026 BSE Limited Phirozee Jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400 001 Scrip Code: 531035_ (ISIN: INE432F01032) Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report dated August 14, 2026 for the quarter ended June 30, 2026, issued by Care Ratings Limited, the Monitoring Agency appointed to monitor utilization of proceeds of the Preferential issue of Compulsorily Convertible Warrants. We request you to kindly take the above information on record and oblige. Thanking You, Yours Faithfully for Ebix Limited (formerly known as “Eraaya Lifespaces Limited”) Urvashi Upadhyay (Company Secretary & Compliance Officer) www. eraayalife. com + 91 1 1 44191919 contact@ eraayalife. com Regd. Office: 54, Janpath, New Delhi, India-1 10001 No. CARE/NRO/GEN/2026-27/1117 The Board of Directors Ebix Limited 54 Janpath, New Delhi-110001 August 14, 2026 Monitoring Agency Report for the quarter ended June 30, 2026-in relation to the preferential issue of compulsory convertible warrants of Ebix We write in our capacity of Monitoring Agency for the Issue for the compulsorily convertible warrants for the amount aggregating to Rs. 218.70 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated February 12, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Akanksha Dutta Assistant Director Akanksha.Dutta@careedge.in CARE Ratings Limited CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 4th Floor, Godrej Coliseum, Somaiya 16B, Noida, Hospital Road, Off Eastern Express Gautam Budh Nagar, Uttar Pradesh -201301 Highway, Sion (East), Mumbai -400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Ebix Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Yes. The company has transferred Rs.46.15 crore towards working capital requirements of the company, its subsidiaries, step-down subsidiaries, joint ventures, and associate entities. As per monitoring account bank statement, Rs.41.65 crore was transferred to Ebix Travels Limited, Rs.2.23 crore to Ebix Technologies Limited and Rs.2.27 crore to Vikas Lifecare Limited. We have not received CC account or any other account statement including purpose, break-up, counterparties, and invoices to assess working capital utilisation in its subsidiaries, step-down subsidiaries, joint ventures, and associate entities, in respect of the funds transferred. (b) Range of Deviation: 10-25% Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal inany security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of CARE Ratings Limited CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 4th Floor, Godrej Coliseum, Somaiya 16B, Noida, Hospital Road, Off Eastern Express Gautam Budh Nagar, Uttar Pradesh -201301 Highway, Sion (East), Mumbai -400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 www.careedge.in CIN-L67190MH1993PLC071691 Signature: Name and designation of the Authorized Signatory: Akanksha Dutta Designation of Authorized person/Signing Authority: Assistant Director CARE Ratings Limited CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 4th Floor, Godrej Coliseum, Somaiya 16B, Noida, Hospital Road, Off Eastern Express Gautam Budh Nagar, Uttar Pradesh -201301 Highway, Sion (East), Mumbai -400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 www.careedge.in CIN-L67190MH1993PLC071691 Disclaimers to MA report: a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditor appointed by the Issuer believed by it to be accurate and reliable. c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report. d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from statutory auditors, lawyers, chartered engineers or other experts, and relies on in its reports. e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / faci [Showing first 8,000 characters — download PDF for full document]